NCT04159623 is a NA clinical trial of Belk Device in Application Site Atrophy, sponsored by Basque Health Service.

Who is sponsoring NCT04159623?

NCT04159623 is sponsored by Basque Health Service.

What drugs are being tested in NCT04159623?

Interventions in NCT04159623: Belk Device, Standard Rehabilitative treatment.

What condition does NCT04159623 study?

NCT04159623 studies Application Site Atrophy.

Is NCT04159623 still recruiting?

NCT04159623 is currently completed. Last updated 2 June 2021.

Last reviewed 2021-06-02 · How we verify

NCT04159623

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Applicability of the Device Belk in the Rehabilitation Process

Completed NA Last updated 2 June 2021

What this trial tests

NA trial testing Belk Device in Application Site Atrophy in 20 participants. Completed in 8 April 2021.

Timeline

10 November 2020

Primary endpoint
8 April 2021

8 April 2021

Quick facts

Lead sponsor	Basque Health Service
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	10 November 2020
Primary completion	8 April 2021
Estimated completion	8 April 2021
Sites	1 location across Spain

Drugs / interventions tested

Belk Device
Standard Rehabilitative treatment

Conditions studied

Application Site Atrophy — all drugs for Application Site Atrophy →

Sponsor

Basque Health Service — full company profile →

Who can join

Adults 18 to 85, any sex, with Application Site Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pilot, interventional, randomized of parallel groups and multicenter clinical trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Basque Health Service trials

Trials by the same sponsor.

NCT06437444 — Asthma Crisis in Paediatrics: Impact of a Care Pathway in Primary and Hospital Care · NA · recruiting
NCT04022850 — De-implementation of Low-value Pharmacological Prescriptions · NA · completed
NCT04658706 — The SEHNeCa Supervised Exercise Project · NA · unknown
NCT04602182 — Effectiveness of Musicotherapy in Weaning From Mechanical Ventilation · NA · unknown
NCT04078113 — Stimulation and Validation of the Pupillary Dilation for the Detection of Pain in Analgosedated Patients Under Mechanica · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04159623 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Basque Health Service
Last refreshed: 2 June 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04159623.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing